Xvivo Perfusion AB (OTCPK:XVIPF)
$ 42.9 1.67 (4.05%) Market Cap: 1.38 Bil Enterprise Value: 1.34 Bil PE Ratio: 67.14 PB Ratio: 7.03 GF Score: 86/100

Q3 2023 Xvivo Perfusion AB Earnings Call Transcript

Oct 24, 2023 / 12:00PM GMT
Release Date Price: $24.5
Operator

Welcome to Xvivo Q3 report for 2023. (Operator Instructions) Now I will hand the conference over to CEO, Christoffer Rosenblad, and CFO, Kristoffer Nordstrom. Please go ahead.

Christoffer Rosenblad;publ;CEO
Xvivo Perfusion AB

()-

Thank you, and welcome you all to the Xvivo's earning call for the third quarter of 2023. Today's presenters are me, Christoffer Rosenblad, CEO, calling in from Gothenburg, Sweden, and we have also Kristoffer Nordstrom, the company CFO, calling in from Philadelphia. And we go to the next slide, which is Slide #3 and Q3 financial at a glance.

I'm both very proud and happy to report that Q3 was another strong quarter with improvement in performance in line with the last 4 quarters we have seen. It's also very encouraging to see that our, scaling up our business model showed an improved adjusted EBITDA that actually came in almost 3x higher versus Q3 last years in terms of Swedish krona. As you see on the slide, sales came in at SEK 147 million, and we posted the third consecutive high organic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot